Search research articles
Contact Us
Filters
Showing results (51-60 of 272) with videos related to
Page
of 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2007
Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer
Sanjay Popat, Yolanda Barbachano, Sue Ashley, et al.
BMC Cancer
|
April 18, 2015
Resolution of severe hyponatraemia is associated with improved survival in patients with cancer
Kirsty Balachandran, Alicia Okines, Ranga Gunapala, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer
Raffaele Califano, Alastair Greystoke, Rohit Lal, et al.
Future Oncology (London, England)
|
March 23, 2017
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options
Sanjay Popat, Anders Mellemgaard, Martin Reck, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 18, 2021
Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score ≥2 - Systematic review and meta-analysis
Bartłomiej Tomasik, Michał Bieńkowski, Marcin Braun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2025
Missed Opportunity for Sotorasib Dose Optimization
Garth W Strohbehn, Jill Feldman, Sanjay Popat, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2022
Targeting un-MET needs in advanced non-small cell lung cancer
Niamh Coleman, Alice Harbery, Sara Heuss, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Severe Immune Checkpoint Inhibitor Hepatitis in <i>KRAS</i> G12C-Mutant NSCLC Potentially Triggered by Sotorasib: Case Report
Parvin Begum, Robert D Goldin, Lucia A Possamai, et al.
Journal of Comparative Effectiveness Research
|
February 25, 2022
Health technology assessments and real-world evidence: tell us what you want, what you really, really want
Frank Griesinger, Oliver Cox, Cormac Sammon, et al.
Nature Reviews. Cancer
|
July 26, 2017
Novel insights into mesothelioma biology and implications for therapy
Timothy A Yap, Joachim G Aerts, Sanjay Popat, et al.
Page
of 28
Search research articles
Search
Showing results (51-60 of 272) with videos related to
Sort By:
Page
of 28
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2007
Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer
Sanjay Popat, Yolanda Barbachano, Sue Ashley, et al.
BMC Cancer
|
April 18, 2015
Resolution of severe hyponatraemia is associated with improved survival in patients with cancer
Kirsty Balachandran, Alicia Okines, Ranga Gunapala, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer
Raffaele Califano, Alastair Greystoke, Rohit Lal, et al.
Future Oncology (London, England)
|
March 23, 2017
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options
Sanjay Popat, Anders Mellemgaard, Martin Reck, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 18, 2021
Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score ≥2 - Systematic review and meta-analysis
Bartłomiej Tomasik, Michał Bieńkowski, Marcin Braun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2025
Missed Opportunity for Sotorasib Dose Optimization
Garth W Strohbehn, Jill Feldman, Sanjay Popat, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2022
Targeting un-MET needs in advanced non-small cell lung cancer
Niamh Coleman, Alice Harbery, Sara Heuss, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Severe Immune Checkpoint Inhibitor Hepatitis in <i>KRAS</i> G12C-Mutant NSCLC Potentially Triggered by Sotorasib: Case Report
Parvin Begum, Robert D Goldin, Lucia A Possamai, et al.
Journal of Comparative Effectiveness Research
|
February 25, 2022
Health technology assessments and real-world evidence: tell us what you want, what you really, really want
Frank Griesinger, Oliver Cox, Cormac Sammon, et al.
Nature Reviews. Cancer
|
July 26, 2017
Novel insights into mesothelioma biology and implications for therapy
Timothy A Yap, Joachim G Aerts, Sanjay Popat, et al.
Page
of 28